Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Christopher Lieu

Concepts (416)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
53
2026
864
9.710
 Why?
Antineoplastic Combined Chemotherapy Protocols
25
2026
1958
2.740
 Why?
Colonic Neoplasms
9
2026
257
2.690
 Why?
Biomarkers, Tumor
23
2026
1320
2.390
 Why?
Molecular Targeted Therapy
9
2019
438
1.860
 Why?
Antineoplastic Agents
14
2021
2207
1.810
 Why?
Antibodies, Monoclonal, Humanized
12
2026
992
1.690
 Why?
Rectal Neoplasms
7
2023
159
1.600
 Why?
Bevacizumab
5
2024
168
1.550
 Why?
Immunotherapy
5
2026
665
1.500
 Why?
Benzimidazoles
3
2024
189
1.460
 Why?
Neoplasms
14
2025
2900
1.390
 Why?
Drug Resistance, Neoplasm
10
2026
881
1.110
 Why?
Microsatellite Instability
11
2026
55
1.110
 Why?
Pancreatic Neoplasms
11
2025
926
1.060
 Why?
Mutation
15
2025
4071
1.030
 Why?
Circulating Tumor DNA
5
2026
46
1.000
 Why?
Neoplasm Staging
14
2026
1467
0.980
 Why?
Age of Onset
9
2024
554
0.960
 Why?
Gastrointestinal Neoplasms
2
2025
71
0.950
 Why?
Tankyrases
1
2025
13
0.910
 Why?
Cetuximab
5
2025
111
0.830
 Why?
Vascular Endothelial Growth Factor A
4
2020
552
0.820
 Why?
Neuroendocrine Tumors
6
2024
119
0.820
 Why?
Fluorouracil
8
2026
230
0.780
 Why?
Proto-Oncogene Proteins p21(ras)
4
2019
254
0.770
 Why?
Humans
109
2026
145140
0.770
 Why?
Oncologists
1
2023
47
0.760
 Why?
Proto-Oncogene Proteins B-raf
6
2024
223
0.730
 Why?
Indoles
1
2025
507
0.680
 Why?
Antibodies, Monoclonal
6
2023
1505
0.670
 Why?
Leucovorin
7
2026
98
0.640
 Why?
Middle Aged
45
2026
36126
0.640
 Why?
Carcinoma, Pancreatic Ductal
4
2025
293
0.640
 Why?
Wnt Signaling Pathway
3
2025
211
0.630
 Why?
Pyrimidinones
2
2024
125
0.630
 Why?
Aged
36
2026
26096
0.610
 Why?
Colectomy
2
2026
106
0.610
 Why?
DNA Mismatch Repair
5
2026
53
0.600
 Why?
Camptothecin
5
2025
138
0.590
 Why?
Pyridones
2
2024
209
0.580
 Why?
Early Detection of Cancer
4
2025
482
0.570
 Why?
Neoplasm Metastasis
9
2025
688
0.570
 Why?
Disease-Free Survival
8
2026
766
0.560
 Why?
Piperidines
2
2017
220
0.560
 Why?
Adult
40
2026
40665
0.540
 Why?
Neoadjuvant Therapy
6
2026
465
0.530
 Why?
Azetidines
1
2017
45
0.510
 Why?
Cyclosporine
1
2018
256
0.510
 Why?
Genetic Predisposition to Disease
4
2022
2351
0.510
 Why?
Terminology as Topic
1
2019
256
0.490
 Why?
Appendiceal Neoplasms
2
2020
28
0.490
 Why?
Chemotherapy, Adjuvant
6
2026
423
0.480
 Why?
Male
47
2026
72664
0.470
 Why?
Precision Medicine
2
2026
459
0.460
 Why?
Neoplasms, Unknown Primary
2
2026
20
0.460
 Why?
Female
48
2026
78636
0.450
 Why?
MAP Kinase Kinase Kinases
1
2015
70
0.450
 Why?
Adrenal Gland Neoplasms
3
2022
98
0.450
 Why?
Patient Rights
1
2015
11
0.440
 Why?
Kaplan-Meier Estimate
7
2025
968
0.440
 Why?
Treatment Outcome
16
2026
11741
0.440
 Why?
Medical Oncology
5
2023
338
0.440
 Why?
Drug and Narcotic Control
1
2015
24
0.440
 Why?
Therapies, Investigational
1
2015
18
0.440
 Why?
Drugs, Investigational
1
2015
31
0.430
 Why?
Neovascularization, Pathologic
2
2013
285
0.430
 Why?
Healthcare Disparities
1
2021
731
0.410
 Why?
Relaxation Therapy
1
2014
19
0.410
 Why?
Leisure Activities
1
2014
30
0.400
 Why?
Adenocarcinoma
5
2023
920
0.390
 Why?
Stroke Rehabilitation
1
2014
43
0.390
 Why?
Pyrazines
2
2018
92
0.390
 Why?
Immunoglobulin G
1
2017
887
0.380
 Why?
Drug Evaluation, Preclinical
1
2013
196
0.380
 Why?
Microsatellite Repeats
2
2024
156
0.380
 Why?
Clinical Trials as Topic
4
2025
1058
0.370
 Why?
Drug Design
1
2013
175
0.370
 Why?
ErbB Receptors
5
2017
635
0.360
 Why?
Xenograft Model Antitumor Assays
7
2025
932
0.340
 Why?
Carcinoma, Signet Ring Cell
1
2011
17
0.340
 Why?
Cell Transformation, Neoplastic
1
2013
337
0.340
 Why?
Terminal Care
1
2015
283
0.330
 Why?
Carcinoma, Squamous Cell
2
2026
640
0.320
 Why?
Imidazoles
2
2024
247
0.320
 Why?
Fibroblast Growth Factors
1
2011
188
0.310
 Why?
Dose-Response Relationship, Drug
3
2025
2026
0.310
 Why?
Organoplatinum Compounds
3
2026
65
0.310
 Why?
src-Family Kinases
1
2010
92
0.300
 Why?
Genomics
4
2025
819
0.290
 Why?
Clinical Decision-Making
4
2024
362
0.290
 Why?
Maximum Tolerated Dose
2
2025
210
0.290
 Why?
Patient Selection
3
2019
733
0.280
 Why?
Boronic Acids
1
2008
36
0.280
 Why?
Disease Management
4
2021
651
0.280
 Why?
Aged, 80 and over
14
2026
8318
0.270
 Why?
Janus Kinase 2
1
2008
29
0.270
 Why?
Myeloproliferative Disorders
1
2008
21
0.270
 Why?
Etoposide
1
2008
167
0.270
 Why?
Carboplatin
1
2008
161
0.270
 Why?
Stomach Neoplasms
3
2022
128
0.270
 Why?
Patient-Centered Care
2
2025
547
0.250
 Why?
Carcinoembryonic Antigen
2
2024
40
0.250
 Why?
Pathology, Molecular
2
2017
25
0.250
 Why?
Pathology, Clinical
2
2017
29
0.250
 Why?
Shock, Septic
1
2009
227
0.250
 Why?
Cancer Survivors
2
2024
337
0.240
 Why?
Health Services Accessibility
1
2015
1099
0.240
 Why?
Drug Administration Schedule
4
2019
781
0.240
 Why?
Organ Sparing Treatments
1
2026
37
0.240
 Why?
B7-H1 Antigen
3
2026
243
0.230
 Why?
ras Proteins
2
2017
150
0.230
 Why?
Oncology Service, Hospital
1
2025
15
0.230
 Why?
Anus Neoplasms
1
2026
32
0.230
 Why?
Ipilimumab
1
2026
40
0.230
 Why?
CD47 Antigen
1
2025
42
0.230
 Why?
Age Factors
5
2021
3338
0.220
 Why?
Diagnosis, Differential
1
2009
1506
0.210
 Why?
United States
14
2025
16065
0.210
 Why?
Oximes
1
2024
26
0.210
 Why?
Fluorescence Resonance Energy Transfer
1
2025
177
0.210
 Why?
Young Adult
6
2026
14176
0.210
 Why?
Benchmarking
1
2025
188
0.210
 Why?
Cell Line, Tumor
6
2025
3539
0.200
 Why?
Prognosis
10
2026
4310
0.200
 Why?
CD3 Complex
1
2024
112
0.200
 Why?
Deoxycytidine
3
2024
220
0.200
 Why?
Metastasectomy
1
2023
19
0.190
 Why?
Antibodies, Bispecific
1
2024
68
0.190
 Why?
Extracellular Vesicles
1
2025
169
0.190
 Why?
Trifluridine
1
2022
3
0.190
 Why?
Clinical Trials, Phase II as Topic
2
2022
75
0.190
 Why?
Signal Transduction
6
2018
5208
0.190
 Why?
Retrospective Studies
11
2026
17247
0.190
 Why?
Neoplasm Grading
2
2024
310
0.180
 Why?
Surgical Oncology
1
2022
30
0.180
 Why?
Empathy
1
2024
181
0.180
 Why?
Clinical Trials, Phase III as Topic
2
2022
116
0.180
 Why?
Academic Medical Centers
1
2025
552
0.180
 Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2023
166
0.180
 Why?
Genetic Testing
3
2022
480
0.180
 Why?
Databases, Factual
4
2017
1488
0.180
 Why?
Ovarian Neoplasms
2
2020
594
0.180
 Why?
Disease Models, Animal
4
2021
4552
0.170
 Why?
Membrane Proteins
3
2019
1163
0.170
 Why?
Chemoradiotherapy, Adjuvant
2
2023
44
0.170
 Why?
Survival Rate
6
2023
2087
0.170
 Why?
Tumor Microenvironment
2
2023
733
0.170
 Why?
Incidence
6
2022
2915
0.170
 Why?
Neoplasms, Multiple Primary
1
2022
58
0.170
 Why?
Gene Regulatory Networks
1
2024
317
0.170
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2022
40
0.170
 Why?
DNA
1
2008
1433
0.170
 Why?
Pheochromocytoma
1
2022
67
0.170
 Why?
Meningioma
1
2022
88
0.160
 Why?
Capecitabine
2
2022
56
0.160
 Why?
Congresses as Topic
2
2019
223
0.160
 Why?
Heterografts
1
2021
143
0.160
 Why?
Health Status Disparities
2
2020
320
0.160
 Why?
Practice Patterns, Physicians'
1
2009
1365
0.150
 Why?
Immune System
1
2021
177
0.150
 Why?
Artificial Intelligence
1
2024
381
0.150
 Why?
Adenomatous Polyposis Coli Protein
1
2019
20
0.150
 Why?
Smad4 Protein
1
2019
34
0.150
 Why?
Area Under Curve
2
2018
329
0.150
 Why?
GTP Phosphohydrolases
1
2019
93
0.140
 Why?
Retinal Vein
1
2019
14
0.140
 Why?
Tumor Suppressor Protein p53
2
2022
532
0.140
 Why?
Animals
12
2025
37952
0.140
 Why?
Prevalence
2
2026
2855
0.140
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
108
0.140
 Why?
Cell-Free Nucleic Acids
1
2019
33
0.140
 Why?
Disease Progression
4
2017
2857
0.140
 Why?
Vasculitis
1
2019
69
0.140
 Why?
Genes, ras
1
2018
96
0.140
 Why?
Neoplasm Transplantation
1
2018
246
0.130
 Why?
Evidence-Based Medicine
2
2019
739
0.130
 Why?
Retinal Diseases
1
2019
101
0.130
 Why?
Proportional Hazards Models
3
2017
1325
0.130
 Why?
Drug Combinations
2
2022
396
0.130
 Why?
Survivorship
1
2018
57
0.130
 Why?
Patient Advocacy
1
2018
73
0.130
 Why?
Acneiform Eruptions
1
2017
1
0.130
 Why?
Cohort Studies
6
2020
5988
0.130
 Why?
Asthenia
1
2017
3
0.130
 Why?
Population Surveillance
1
2021
484
0.130
 Why?
Risk Factors
6
2022
10857
0.130
 Why?
Drug Eruptions
1
2017
28
0.130
 Why?
Hypokalemia
1
2017
24
0.130
 Why?
Risk Assessment
2
2019
3740
0.130
 Why?
Histone Deacetylase Inhibitors
1
2019
218
0.130
 Why?
MAP Kinase Kinase 1
1
2017
70
0.130
 Why?
Patient Compliance
1
2021
587
0.130
 Why?
Receptor, ErbB-3
1
2017
48
0.130
 Why?
Intercellular Signaling Peptides and Proteins
2
2015
376
0.130
 Why?
Consensus
1
2019
478
0.120
 Why?
Esophageal Neoplasms
1
2021
345
0.120
 Why?
Programmed Cell Death 1 Receptor
1
2019
264
0.120
 Why?
Digestive System Neoplasms
1
2016
9
0.120
 Why?
Antineoplastic Agents, Immunological
1
2019
198
0.120
 Why?
Neoplasm Recurrence, Local
2
2023
1146
0.120
 Why?
Liver Neoplasms
2
2024
775
0.120
 Why?
Insulin-Like Growth Factor I
1
2018
317
0.120
 Why?
Adolescent
5
2026
22479
0.120
 Why?
Edema
1
2016
125
0.120
 Why?
Time Factors
2
2019
7107
0.120
 Why?
Hospitals
1
2021
732
0.120
 Why?
Biomarkers
3
2023
4282
0.120
 Why?
Triple Negative Breast Neoplasms
1
2019
218
0.120
 Why?
GPI-Linked Proteins
1
2016
81
0.110
 Why?
Diabetic Neuropathies
1
2016
100
0.110
 Why?
Biliary Tract Neoplasms
1
2015
31
0.110
 Why?
Device Approval
1
2015
19
0.110
 Why?
Immunoblotting
1
2015
295
0.110
 Why?
Receptor, Notch1
1
2015
63
0.110
 Why?
Mice
7
2025
18303
0.110
 Why?
Neuralgia
1
2016
140
0.110
 Why?
Patient Care Planning
1
2016
170
0.110
 Why?
Health Behavior
1
2020
787
0.110
 Why?
Gene Dosage
1
2015
145
0.110
 Why?
Pancreas
1
2017
341
0.110
 Why?
Delivery of Health Care, Integrated
1
2018
299
0.110
 Why?
Analgesics
1
2016
230
0.110
 Why?
Gene Expression Regulation
1
2024
2588
0.110
 Why?
Drug Approval
1
2015
93
0.110
 Why?
Administration, Oral
1
2017
862
0.110
 Why?
DNA Copy Number Variations
1
2015
183
0.110
 Why?
Genetic Variation
1
2019
967
0.100
 Why?
Quality of Life
2
2024
3194
0.100
 Why?
Quinazolines
1
2015
266
0.100
 Why?
Immunoconjugates
1
2016
138
0.100
 Why?
Phenotype
2
2021
3138
0.100
 Why?
United States Food and Drug Administration
1
2015
207
0.100
 Why?
Delivery of Health Care
1
2021
946
0.100
 Why?
Proto-Oncogene Proteins
1
2017
623
0.100
 Why?
Oligonucleotide Array Sequence Analysis
1
2015
749
0.100
 Why?
Liquid Biopsy
2
2025
15
0.100
 Why?
beta Catenin
1
2015
254
0.100
 Why?
Lung Neoplasms
2
2024
2662
0.100
 Why?
Spinal Cord Injuries
1
2016
234
0.100
 Why?
Lymphocytes
1
2015
376
0.100
 Why?
National Cancer Institute (U.S.)
2
2025
54
0.090
 Why?
Randomized Controlled Trials as Topic
1
2019
1742
0.090
 Why?
Registries
1
2021
2401
0.090
 Why?
Risk
1
2014
916
0.090
 Why?
Protein Kinase Inhibitors
1
2018
979
0.090
 Why?
Angiogenesis Inhibitors
1
2013
238
0.090
 Why?
Ligands
1
2013
664
0.090
 Why?
Neoplasm, Residual
2
2022
143
0.080
 Why?
Prospective Studies
3
2022
8035
0.080
 Why?
Patient Care Team
1
2016
696
0.080
 Why?
Protein-Tyrosine Kinases
1
2013
431
0.080
 Why?
Activities of Daily Living
1
2014
439
0.080
 Why?
Apoptosis
3
2022
2434
0.080
 Why?
Mice, Nude
2
2024
679
0.080
 Why?
Streptococcaceae
1
2009
2
0.070
 Why?
Cytokines
2
2015
2048
0.070
 Why?
Neutrophils
1
2015
1123
0.070
 Why?
Clinical Medicine
1
2009
26
0.070
 Why?
Transcriptome
1
2015
1029
0.070
 Why?
Patient Satisfaction
1
2013
708
0.070
 Why?
Chemoradiotherapy
2
2023
239
0.070
 Why?
Myositis
1
2009
57
0.070
 Why?
Sulindac
1
2008
16
0.070
 Why?
Bortezomib
1
2008
54
0.070
 Why?
Mutation Rate
2
2019
30
0.070
 Why?
Taiwan
1
2008
48
0.070
 Why?
Combined Modality Therapy
1
2011
1264
0.070
 Why?
Nausea
1
2008
112
0.070
 Why?
Immunoenzyme Techniques
1
2008
200
0.070
 Why?
Multivariate Analysis
3
2017
1546
0.070
 Why?
Neutropenia
1
2008
154
0.060
 Why?
Fluphenazine
1
2007
4
0.060
 Why?
Risperidone
1
2007
30
0.060
 Why?
Nerve Fibers, Myelinated
1
2007
47
0.060
 Why?
Food
1
2008
150
0.060
 Why?
Drug Therapy, Combination
1
2010
1043
0.060
 Why?
Exons
1
2008
363
0.060
 Why?
Anemia
1
2008
190
0.060
 Why?
Fasting
1
2008
276
0.060
 Why?
Thrombocytopenia
1
2008
204
0.060
 Why?
Frontal Lobe
1
2007
160
0.060
 Why?
Administrative Personnel
1
2025
33
0.060
 Why?
Gastrectomy
2
2017
163
0.060
 Why?
Propensity Score
2
2017
374
0.050
 Why?
Antipsychotic Agents
1
2007
211
0.050
 Why?
Polymerase Chain Reaction
1
2008
1039
0.050
 Why?
Stroke
1
2014
1270
0.050
 Why?
Postoperative Complications
1
2017
2961
0.050
 Why?
Follow-Up Studies
2
2026
5411
0.050
 Why?
Survival Analysis
2
2017
1371
0.050
 Why?
Loneliness
1
2024
63
0.050
 Why?
Fluorescent Dyes
1
2025
333
0.050
 Why?
Health Care Surveys
1
2025
535
0.050
 Why?
Delayed Diagnosis
1
2024
100
0.050
 Why?
Natural Language Processing
1
2024
106
0.050
 Why?
Oxidative Stress
1
2010
1351
0.050
 Why?
Thymine
1
2022
16
0.050
 Why?
Cyclooxygenase 2 Inhibitors
1
2022
24
0.050
 Why?
Paclitaxel
1
2024
256
0.050
 Why?
G2 Phase Cell Cycle Checkpoints
1
2022
44
0.050
 Why?
Recombinant Fusion Proteins
1
2025
666
0.050
 Why?
Equivalence Trials as Topic
1
2022
35
0.050
 Why?
Mice, Inbred BALB C
1
2025
1261
0.050
 Why?
Endothelial Growth Factors
1
2022
62
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
68
0.050
 Why?
Resilience, Psychological
1
2024
149
0.050
 Why?
Gallium Radioisotopes
1
2022
16
0.050
 Why?
Receptors, Peptide
1
2022
18
0.050
 Why?
Radioisotopes
1
2022
37
0.050
 Why?
Intestinal Neoplasms
1
2022
30
0.040
 Why?
Radionuclide Imaging
1
2022
115
0.040
 Why?
Inflammasomes
1
2023
144
0.040
 Why?
Organoids
1
2024
144
0.040
 Why?
Pyrrolidines
1
2022
125
0.040
 Why?
Neoplastic Syndromes, Hereditary
1
2021
47
0.040
 Why?
North America
1
2022
301
0.040
 Why?
Quinolines
1
2022
190
0.040
 Why?
Radiopharmaceuticals
1
2022
205
0.040
 Why?
Europe
1
2022
416
0.040
 Why?
Positron Emission Tomography Computed Tomography
1
2022
117
0.040
 Why?
Chimerism
1
2021
35
0.040
 Why?
Preventive Medicine
1
2021
39
0.040
 Why?
Immune Tolerance
1
2023
385
0.040
 Why?
Lymphocyte Subsets
1
2021
77
0.040
 Why?
Surveys and Questionnaires
2
2024
6055
0.040
 Why?
Canada
1
2022
429
0.040
 Why?
Lymphoid Tissue
1
2021
77
0.040
 Why?
Hyaluronic Acid
1
2022
225
0.040
 Why?
Positron-Emission Tomography
1
2022
343
0.040
 Why?
Geography
1
2020
185
0.040
 Why?
Mice, SCID
1
2021
369
0.040
 Why?
Morbidity
1
2021
322
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2022
231
0.040
 Why?
SEER Program
1
2020
229
0.040
 Why?
Mice, Inbred C57BL
2
2023
5972
0.040
 Why?
Mice, Inbred NOD
1
2021
613
0.040
 Why?
Spectrophotometry, Infrared
1
2019
53
0.040
 Why?
District of Columbia
1
2018
38
0.030
 Why?
Sulfonamides
1
2022
583
0.030
 Why?
Karnofsky Performance Status
1
2018
37
0.030
 Why?
Pyridines
1
2022
608
0.030
 Why?
Structure-Activity Relationship
1
2019
563
0.030
 Why?
Melanoma
1
2024
759
0.030
 Why?
Multimodal Imaging
1
2019
129
0.030
 Why?
Lymphocytes, Tumor-Infiltrating
1
2019
153
0.030
 Why?
Fluorescein Angiography
1
2019
190
0.030
 Why?
Colon
1
2020
308
0.030
 Why?
RNA
1
2024
910
0.030
 Why?
Half-Life
1
2017
153
0.030
 Why?
American Medical Association
1
2017
19
0.030
 Why?
Genome, Human
1
2019
419
0.030
 Why?
Gene Expression Profiling
1
2024
1763
0.030
 Why?
Tomography, Optical Coherence
1
2019
271
0.030
 Why?
Needles
1
2016
62
0.030
 Why?
Reproducibility of Results
1
2024
3410
0.030
 Why?
Cell Proliferation
1
2024
2504
0.030
 Why?
Radiotherapy, Adjuvant
1
2017
221
0.030
 Why?
Delphi Technique
1
2018
330
0.030
 Why?
Genomic Instability
1
2017
67
0.030
 Why?
Infusions, Intravenous
1
2017
428
0.030
 Why?
Radiotherapy, Intensity-Modulated
1
2017
142
0.030
 Why?
Health Services Needs and Demand
1
2018
279
0.030
 Why?
Molecular Diagnostic Techniques
1
2017
103
0.030
 Why?
Meta-Analysis as Topic
1
2017
169
0.030
 Why?
Retreatment
1
2016
79
0.030
 Why?
Algorithms
1
2024
1845
0.030
 Why?
DNA Mutational Analysis
1
2017
407
0.030
 Why?
Incidental Findings
1
2016
81
0.030
 Why?
Platinum
1
2016
48
0.030
 Why?
Acute Disease
1
2019
1035
0.030
 Why?
Serrate-Jagged Proteins
1
2015
27
0.030
 Why?
Jagged-1 Protein
1
2015
22
0.030
 Why?
Gene Frequency
1
2017
484
0.030
 Why?
Neoplasm Invasiveness
1
2017
506
0.030
 Why?
Radiography
2
2016
852
0.030
 Why?
Gene Duplication
1
2015
66
0.030
 Why?
Endoscopy, Digestive System
1
2016
141
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
698
0.030
 Why?
Protein Isoforms
1
2016
396
0.030
 Why?
Practice Guidelines as Topic
1
2022
1579
0.030
 Why?
Preoperative Care
1
2017
380
0.030
 Why?
Leukocyte Count
1
2015
316
0.030
 Why?
Analysis of Variance
1
2017
1300
0.030
 Why?
Magnetic Resonance Imaging
1
2007
3892
0.030
 Why?
Calcium-Binding Proteins
1
2015
221
0.030
 Why?
Ultraviolet Rays
1
2016
384
0.030
 Why?
Mice, Knockout
1
2021
3114
0.030
 Why?
Societies, Medical
1
2018
898
0.020
 Why?
Behavior, Animal
1
2016
519
0.020
 Why?
Protein Processing, Post-Translational
1
2016
469
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2019
917
0.020
 Why?
Brain Neoplasms
1
2021
1328
0.020
 Why?
Logistic Models
1
2017
2133
0.020
 Why?
Skin
1
2016
753
0.020
 Why?
Immunohistochemistry
1
2016
1713
0.020
 Why?
Rats, Sprague-Dawley
1
2016
2524
0.020
 Why?
Cross-Sectional Studies
1
2022
5886
0.020
 Why?
Lung
1
2023
4101
0.020
 Why?
Protein Binding
1
2016
2235
0.020
 Why?
Angiogenesis Inducing Agents
1
2009
25
0.020
 Why?
Glycogen Synthase Kinase 3 beta
1
2008
74
0.020
 Why?
Rats
1
2016
5582
0.020
 Why?
Glycogen Synthase Kinase 3
1
2008
83
0.020
 Why?
Reference Standards
1
2008
177
0.020
 Why?
Pharmacogenetics
1
2008
174
0.020
 Why?
Infusions, Intra-Arterial
1
1986
61
0.010
 Why?
Hepatic Artery
1
1986
53
0.010
 Why?
Chromatography, High Pressure Liquid
1
2008
591
0.010
 Why?
Breast Neoplasms
1
2019
2380
0.010
 Why?
Predictive Value of Tests
1
2011
2115
0.010
 Why?
Reference Values
1
2007
798
0.010
 Why?
Tomography, X-Ray Computed
1
2016
2767
0.010
 Why?
Tandem Mass Spectrometry
1
2008
571
0.010
 Why?
Image Processing, Computer-Assisted
1
2007
777
0.010
 Why?
Longitudinal Studies
1
2007
2949
0.010
 Why?
Lieu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (416) concept(s)
_
Co-Authors Expand Description
See all (79) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)